Zhejiang Huahai Pharmaceutical Co., Ltd. (SHA:600521)

Market Cap	20.65B
Revenue (ttm)	9.35B
Net Income (ttm)	1.14B
Shares Out	1.45B
EPS (ttm)	0.78
PE Ratio	18.27
Forward PE	13.57
Dividend	0.20 (1.42%)
Ex-Dividend Date	Jul 10, 2024

Volume	6,411,840
Average Volume	20,194,211
Open	14.19
Previous Close	14.08
Day's Range	14.15 - 14.40
52-Week Range	13.49 - 21.55
Beta	0.50
RSI	40.47
Earnings Date	Apr 30, 2025

About SHA:600521

Zhejiang Huahai Pharmaceutical Co., Ltd. operates as a pharmaceutical company in China and internationally. The company offers central neurological, cardiovascular, anti-viral, and other products, as well as APIs and intermediates. It also provides packaging components, such as high-density polyethylene bottles and polypropylene caps for pharmaceuticals. In addition, the company offers contract manufacturing and other services, as well as import and export trade services. The company was founded in 1989 and is headquartered in Linhai, China.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1989
• Employees: 8,221
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 600521

Financial Performance

In 2023, SHA:600521's revenue was 8.31 billion, an increase of 0.52% compared to the previous year's 8.27 billion. Earnings were 830.47 million, a decrease of -28.88%.